[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100525609":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":13,"centralContacts":17,"locations":23,"responsibleParty":38,"collaborators":7,"id":41,"slug":42,"hasResults":43,"nctId":44,"briefTitle":45,"officialTitle":46,"acronym":7,"eligibilityCriteria":47,"healthyVolunteers":43,"sex":48,"minAge":49,"maxAge":7,"enrollmentInfo":50,"targetDuration":7,"studyType":53,"phases":7,"briefSummary":54,"conditions":55,"keywords":57,"overallStatus":25,"whyStopped":7,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":64,"completionDateStruct":66,"leadSponsor":68,"locationsCount":69},{"fullName":5,"class":6},"China-Japan Friendship Hospital","OTHER",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"PROCEDURE","Collect peripheral blood and bronchoalveolar lavage fluid","Peripheral venous blood will be collected and stored from the study participants at a total of five time points: Day 0, Day 1, Day 2, Day 3 after admission to the ICU, and the day of ICU discharge\u002Fdeath. The collection will be conducted after assessing the patients' eligibility for ARDS diagnosis. Each time point will involve the collection of one tube of peripheral venous blood, totaling 5 mL per sample.\n\nWithin 24 hours after patients' admission to the ICU and meeting the assessment criteria for ARDS diagnosis, bronchoalveolar lavage fluid (BALF) will be collected and retained, totaling 10 mL.",[14],{"name":15,"affiliation":5,"role":16},"Jingen Xia","STUDY_DIRECTOR",[18],{"name":19,"role":20,"phone":21,"phoneExt":7,"email":22},"Jingen Xia, M.D","CONTACT","+8613466396561","13466396561@163.com",[24],{"facility":15,"status":25,"city":26,"state":7,"zip":7,"country":27,"countryCode":28,"cosmosGeoPoint":29,"geoPoint":34,"contacts":35},"RECRUITING","Beijing","China","CN",{"type":30,"coordinates":31},"Point",[32,33],116.39723,39.9075,{"lat":33,"lon":32},[36],{"name":37,"role":20,"phone":7,"phoneExt":7,"email":7},"Jingen Xia, MD",{"type":39,"investigatorFullName":15,"investigatorTitle":40,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Clinical Professor","100525609","aliards-clinical-sub-phenotyping-study-100525609",false,"NCT06123962","ALI\u002FARDS Clinical Sub-phenotyping Study","Acute Lung\u002F Acute Respiratory Distress Syndrome and Extra-pulmonary Organ Injury Clinical Sub-phenotyping Study","Inclusion Criteria:\n\n* Meet the diagnostic criteria for Acute Respiratory Distress Syndrome (ARDS) according to the updated global definition in 2023.\n* The patient or their legal representative signs an informed consent form.\n\nExclusion Criteria:\n\n* Individuals aged less than 18 years old.\n* Those who refuse to participate in the study.","ALL","18 Years",{"count":51,"type":52},1500,"ESTIMATED","OBSERVATIONAL","1. Construct a structured clinical data and biosample information platform for Chinese patients with acute lung injury\u002F acute respiratory distress syndrome.\n2. By deciphering the heterogeneity of patients with acute lung injury\u002F acute respiratory distress syndrome, achieve clinical, longitudinal physiological, and biological sub-phenotyping to guide individualized precision treatment and improve prognosis.",[56],"Acute Lung Injury\u002FAcute Respiratory Distress Syndrome (ARDS)",[56,58,59],"Sub-phenotypes","Treatment strategies","2025-02-10",{"date":62,"type":63},"2025-02-12","ACTUAL",{"date":65,"type":63},"2023-12-14",{"date":67,"type":52},"2025-12-31",{"name":5,"class":6},1]